This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
Returning October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Returning October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Returning in 2024! More Information Coming Soon...

ASIA’S LEADING CONFERENCE FOR ACCELERATING ANTIBODY & PROTEIN THERAPEUTICS, ADC’s, BISPECIFICS AND IMMUNO-ONCOLOGY

Bringing together the antibody community to discuss the latest critical insights on antibody discovery and engineering, bispecific antibodies, antibody drug conjugates, multispecifics, immuno-oncology and much more...

Key Antibody Research, Cutting-Edge Technology, and Unrivaled Networking Opportunities

Case Studies, New Data & Lessons Learned From Antibody Programs Covering:

  • Bispecific and Multispecific Antibodies
  • Antibodies for Novel/Challenging Targets
  • Immune Cell Engager Antibody Technologies
  • Antibody-Drug Conjugates
  • Disease-Area Specific Antibodies

Case Studies, New Data & Lessons Learned From Antibody Programs Covering:

  • AI/Machine Learning for Antibody Developability
  • New Binders, Therapeutic Modalities & Antibody Formats
  • Agonist Antibodies and Conditional Antibodies
  • Novel Antibody Technologies and Applications
  • Preclinical and Clinical Antibody Case Studies

The Return to Japan in 2024:

After a break for 3 years, we are pleased to announce the return to Japan in October 2024. Join pioneers in the antibody community as they dive into the critical updates within the industry. You'll have the opportunity to network with peers from across the globe in the vibrant city of Kyoto - renowned for developing many of the refined arts that are now associated with Japan.